Gil Yedidya Melmed

Title(s)HS Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Am J Gastroenterol. 2025 Apr 07. Melmed GY, Oliver B, Kennedy A, Hou JK, Lum D, Singh S, van Deen WK, Oberai R, Weaver SA, Testaverde J, Siegel CA, IBD Qorus. PMID: 40192134.
      View in: PubMed   Mentions:    Fields:    
    2. Development and Clinical Evaluation of a Multiplexed Health Surveillance Panel Using Ultra High-Throughput PRM-MS in an Inflammatory Bowel Disease Cohort. bioRxiv. 2025 Apr 04. Fu Q, Remes PM, Lee J, Jacob C, Li D, Vegesna M, Raedschelders K, Haghani A, Mengesha E, Debbas P, Hoedt E, Joung S, Cheng S, Peterman S, Fert-Bober J, Melmed GY, McGovern DPB, Murray CI, Van Eyk JE. PMID: 40236053; PMCID: PMC11996553.
      View in: PubMed   Mentions:
    3. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1). Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. PMID: 40164445; PMCID: PMC11962770.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    4. Predictive Factors of Inactive Patient Participation in an Inflammatory Bowel Disease Learning Health System: A Longitudinal Cohort Study. Inflamm Bowel Dis. 2025 Feb 06; 31(2):593-596. Dang N, Kumar S, Kwon M, Cradeur M, Zeven K, Khunte M, Marino D, Tse CS, van Deen WK, Lee A, Kamp K, Oberai R, Melmed GY, Siegel CA, Weaver SA, Shah SA. PMID: 38775837.
      View in: PubMed   Mentions:    Fields:    
    5. Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials. Crohns Colitis 360. 2025 Apr; 7(2):otaf002. Abraham B, Wu J, Vermeire S, Melmed G, Ungaro R, Charabaty A, Moses R, Chan-Diehl F, Paulissen J, Zhu B, Barnes EL, Ehrlich AC, Rubin DT. PMID: 40260308; PMCID: PMC12010086.
      View in: PubMed   Mentions:
    6. Increased gastrointestinal bleeding-related mortality during the COVID-19 pandemic. Therap Adv Gastroenterol. 2025; 18:17562848241311006. Gao X, Yeo YH, Lv F, He X, Park J, Samaan J, Zhao Y, Han Ng W, Wang J, Ji F, Melmed GY. PMID: 39758969; PMCID: PMC11694306.
      View in: PubMed   Mentions:
    7. Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2024 11 04; 30(11):2217-2226. Hashash JG, Yu Ci Ng F, Farraye FA, Wang Y, Colucci DR, Baxi S, Muneer S, Reddan M, Shingru P, Melmed GY. PMID: 38547325.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Progression of Crohn's Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data. Dig Dis Sci. 2024 Nov; 69(11):4167-4177. Fan Y, Zhang L, Omidakhsh N, Bohn RL, Putnam K, Adewale AS, Melmed GY. PMID: 39438411; PMCID: PMC11567996.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Measurement Is Necessary But Not Sufficient to Improve Quality of Care for Patients With Inflammatory Bowel Disease. J Crohns Colitis. 2024 Oct 15; 18(10):1529-1530. Siegel CA, Melmed GY. PMID: 39178333.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study. Inflamm Bowel Dis. 2024 10 03; 30(10):1907-1910. Syal G, Mishkin DS, Banty A, Lee S, Fontelera N, Hampton M, Ziring D, Fleshner PR, Melmed GY. PMID: 37898112.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials. JAMA. 2024 09 17; 332(11):881-897. Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV, INSPIRE and COMMAND Study Group. PMID: 39037800; PMCID: PMC11264075.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    12. A Hybrid Markov-SPC Approach to Assess Cost Differences in Urgent Care Utilization Using Patient-Reported Data in Inflammatory Bowel Disease. Perm J. 2024 09 16; 28(3):234-244. Oliver BJ, Melmed GY, Siegel CA, Kennedy AM, Testaverde J, Oberai R, Alandra Weaver S, Almario C. PMID: 39252533; PMCID: PMC11404662.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Imaging in Inflammatory Bowel Disease. Rheum Dis Clin North Am. 2024 11; 50(4):721-733. Kumar R, Melmed GY, Gu P. PMID: 39415376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate With C-Reactive Protein Among Inpatients With Acute Severe Ulcerative Colitis: A Pilot Study. Crohns Colitis 360. 2024 Jul; 6(3):otae043. Rotondo-Trivette S, Castelan VC, Mathur K, Yasmeh P, Kraus A, Lynch A, McGovern DPB, Melmed GY. PMID: 39206451; PMCID: PMC11350077.
      View in: PubMed   Mentions:
    15. Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons. Adv Ther. 2024 Oct; 41(10):3832-3849. Reinisch W, Melmed GY, Nakase H, Seidelin J, Ma C, Xuan S, Tran J, Remple V, Wegrzyn L, Levy G, Sanchez Gonzalez Y, Panaccione R. PMID: 39126596; PMCID: PMC11399208.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Successful Outcome Treating Pyoderma Gangrenosum and Pouchitis With Upadacitinib. ACG Case Rep J. 2024 Aug; 11(8):e01442. Prieto Jimenez PM, Tabib S, Abbott B, Melmed G. PMID: 39139848; PMCID: PMC11319309.
      View in: PubMed   Mentions: 1  
    17. Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 08 01; 30(8):1430-1434. Lee YJ, Li D, Mujukian A, Debbas P, Hampton M, Mengesha E, Cheng S, Ebinger JE, Chiorean M, Lum D, Damas OM, Braun J, McGovern DPB, Melmed GY, CORALE-IBD Study Group. PMID: 37773982; PMCID: PMC11291623.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease. Am J Gastroenterol. 2025 Feb 01; 120(2):420-430. Systrom HK, Rai V, Singh S, Baidoo L, Cheifetz AS, Devlin SM, Gecse KB, Irving PM, Kaplan GG, Kozuch PL, Ullman T, Sparrow MP, Melmed GY, Siegel CA. PMID: 39008539.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Excess non-COVID-19-related mortality among inflammatory bowel disease decedents during the COVID-19 pandemic. World J Gastroenterol. 2024 May 28; 30(20):2677-2688. Rotondo-Trivette S, He XY, Samaan JS, Lv F, Truong E, Juels M, Nguyen A, Gao X, Zu J, Yeo YH, Ji FP, Melmed GY. PMID: 38855149; PMCID: PMC11154683.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    20. Prevalence, incidence, and treatment patterns of fistulizing Crohn disease: A US population-based cohort study. J Manag Care Spec Pharm. 2024 May; 30(5):420-429. Fan Y, Zhang L, Melmed GY. PMID: 38701028; PMCID: PMC11070649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independent. Photodiagnosis Photodyn Ther. 2024 Jun; 47:104097. Leite G, Mehravar S, Pimentel M, Mathur R, Melmed GY, Teagle V, Barlow GM, Rezaie A. PMID: 38677499.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    22. Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. Inflamm Bowel Dis. 2024 04 03; 30(4):602-616. Mujukian A, Kumar R, Li D, Debbas P, Botwin GJ, Cheng S, Ebinger J, Braun J, McGovern D, Melmed GY, CORALE-IBD Study Group. PMID: 37556401; PMCID: PMC12102483.
      View in: PubMed   Mentions:    Fields:    
    23. Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease. World J Gastrointest Surg. 2024 Mar 27; 16(3):740-750. Gu P, Dube S, Gellada N, Choi SY, Win S, Lee YJ, Yang S, Haritunians T, Melmed GY, Vasiliauskas EA, Bonthala N, Syal G, Yarur AJ, Ziring D, Rabizadeh S, Fleshner P, Kallman C, Devkota S, Targan SR, Li D, McGovern DP. PMID: 38577075; PMCID: PMC10989343.
      View in: PubMed   Mentions:
    24. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology. 2024 Jul; 167(2):315-332. Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, Mengesha E, Li D, Naito T, Bonthala NN, Ha C, Melmed G, Rabizadeh S, Syal G, Vasiliauskas E, Ziring D, Brant SR, Cho J, Duerr RH, Rioux J, Schumm P, Silverberg M, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Xavier RJ, Kugathasan S, Hercules D, Targan SR, Sartor RB, Haritunians T, McGovern DPB. PMID: 38490347; PMCID: PMC11193636.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. A randomized controlled trial of a proactive analgesic protocol demonstrates reduced opioid use among hospitalized adults with inflammatory bowel disease. Sci Rep. 2023 12 16; 13(1):22396. Berry SK, Takakura W, Patel D, Govalan R, Ghafari A, Kiefer E, Huang SC, Bresee C, Nuckols TK, Melmed GY. PMID: 38104145; PMCID: PMC10725490.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    26. Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD). Dig Dis Sci. 2024 Jan; 69(1):235-245. Gu P, Dube S, Lee Y, Yang S, Li D, Haritunians T, Vasiliauskas E, Bonthala N, Syal G, Yarur A, Ziring D, Targan S, Rabizadeh S, Melmed GY, Fleshner P, McGovern DPB. PMID: 38015321; PMCID: PMC10787872.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. Int J Mol Sci. 2023 Sep 18; 24(18). Li D, Pavlovitch-Bedzyk AJ, Ebinger JE, Khan A, Hamideh M, Merchant A, Figueiredo JC, Cheng S, Davis MM, McGovern DPB, Melmed GY, Xu AM, Braun J. PMID: 37762524; PMCID: PMC10531868.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    28. Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT. J Med Internet Res. 2023 08 23; 25:e42921. Long MD, van Deen WK, Weisbein L, Khalil C, Appel KL, Zhang X, Chen W, Zubrod L, Maris R, Ghafari A, Dupuy T, Ha CY, Spiegel BMR, Almario CV, Melmed GY. PMID: 37610821; PMCID: PMC10483303.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    29. Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment. Inflamm Bowel Dis. 2023 08 01; 29(8):1255-1262. Kamp KJ, Hawes SE, Tse CS, Singh S, Dang N, Oberai R, Weaver SA, Melmed GY, Siegel CA, van Deen WK, IBD Qorus. PMID: 36179129; PMCID: PMC10393067.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology. 2023 10; 165(4):963-975.e5. Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P. PMID: 37499955; PMCID: PMC10589067.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. Inflamm Bowel Dis. 2023 06 01; 29(6):883-887. Li D, Debbas P, Mujukian A, Cheng S, Braun J, McGovern DPB, Melmed GY, CORALE-IBD Study Group. PMID: 35998072; PMCID: PMC9452161.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    32. Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission. Am J Gastroenterol. 2023 11 01; 118(11):2005-2013. Yarur AJ, Abreu MT, Deepak P, Beniwal-Patel P, Papamichael K, Vaughn B, Bruss A, Sekhri S, Moosreiner A, Gu P, Kennedy W, Dubinsky M, Cheifetz A, Melmed GY. PMID: 37207314; PMCID: PMC10720850.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut. 2023 11; 72(11):2068-2080. Akhlaghpour M, Haritunians T, More SK, Thomas LS, Stamps DT, Dube S, Li D, Yang S, Landers CJ, Mengesha E, Hamade H, Murali R, Potdar AA, Wolf AJ, Botwin GJ, Khrom M, International IBD Genetics Consortium, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Sartor RB, Xavier RJ, Brant SR, Cho JH, Duerr RH, Lazarev MG, Rioux JD, Schumm LP, Silverberg MS, Zaghiyan K, Fleshner P, Melmed GY, Vasiliauskas EA, Ha C, Rabizadeh S, Syal G, Bonthala NN, Ziring DA, Targan SR, Long MD, McGovern DPB, Michelsen KS. PMID: 37080587; PMCID: PMC11036449.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United States. J Manag Care Spec Pharm. 2023 Apr; 29(4):400-408. Fan Y, Zhang L, Jiménez MC, Bohn RL, Thompson JS, Brodovicz KG, Gray S, Melmed GY. PMID: 36989446; PMCID: PMC10387957.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. Crohns Colitis 360. 2023 Apr; 5(2):otad009. Panaccione R, Collins EB, Melmed GY, Vermeire S, Danese S, Higgins PDR, Kwon CS, Zhou W, Ilo D, Sharma D, Sanchez Gonzalez Y, Wang ST. PMID: 36998249; PMCID: PMC10045885.
      View in: PubMed   Mentions: 20  
    36. Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. J Intern Med. 2023 04; 293(4):520-523. Ebinger JE, Joung SY, Wang M, Liu Y, Prostko JC, Frias EC, Stewart JL, Braun J, McGovern DPB, Melmed GY, Jordan SC, Claggett BL, Sobhani K, Cheng S. PMID: 36625223; PMCID: PMC10714121.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    37. Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2023 01 05; 29(1):85-96. Winthrop KL, Vermeire S, Long MD, Panés J, Ng SC, Kulisek N, Mundayat R, Lawendy N, Vranic I, Modesto I, Su C, Melmed GY. PMID: 35648151; PMCID: PMC9825290.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    38. Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study. Inflamm Bowel Dis. 2023 01 05; 29(1):161-166. Tse CS, Melmed GY, Siegel CA, Weng CH, Shah SA, Weaver SA, Oliver BJ, Elwyn G, van Deen WK. PMID: 35640124.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine. Dig Dis Sci. 2023 02; 68(2):404-413. Syal G, Melmed GY, Almario CV, Spiegel BMR. PMID: 36512266.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Inflammatory Bowel Disease Patients' Preferences for Subcutaneous versus Intravenous Therapies: A Mixed-Methods Study. Dig Dis. 2023; 41(3):412-421. van Deen WK, Khalil C, Bonthala NN, Gale R, Patel DB, Warui E, Melmed GY, Spiegel BMR. PMID: 36476714.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Aliment Pharmacol Ther. 2023 01; 57(2):205-214. Zisman-Ilani Y, Thompson KD, Siegel LS, Mackenzie T, Crate DJ, Korzenik JR, Melmed GY, Kozuch P, Sands BE, Rubin DT, Regueiro MD, Cross R, Wolf DC, Hanson JS, Schwartz RM, Vrabie R, Kreines MD, Scherer T, Dubinsky MC, Siegel CA. PMID: 36377259; PMCID: PMC9790033.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 08; 21(9):2359-2369.e5. Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. PMID: 36343846.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    43. Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management. R I Med J (2013). 2022 Nov 01; 105(9):25-29. Marino D, Singh S, Hou J, Siegel C, Melmed G, Shah SA. PMID: 36300960.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. Clin Gastroenterol Hepatol. 2023 10; 21(11):2908-2917.e10. Yarur AJ, McGovern D, Abreu MT, Cheifetz A, Papamichail K, Deepak P, Bruss A, Beniwal-Patel P, Dubinsky M, Targan SR, Melmed GY. PMID: 36280102.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study. Inflamm Bowel Dis. 2022 10 03; 28(10):1565-1572. Tse CS, Siegel CA, Weaver SA, Oliver BJ, Bresee C, van Deen WK, Melmed GY. PMID: 34893849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome. Genome Med. 2022 08 15; 14(1):91. Jacobs JP, Goudarzi M, Lagishetty V, Li D, Mak T, Tong M, Ruegger P, Haritunians T, Landers C, Fleshner P, Vasiliauskas E, Ippoliti A, Melmed G, Shih D, Targan S, Borneman J, Fornace AJ, McGovern DPB, Braun J. PMID: 35971134; PMCID: PMC9377146.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    47. The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy. Inflamm Bowel Dis. 2022 07 01; 28(7):1130-1133. Li D, Xu A, Mengesha E, Elyanow R, Gittelman RM, Chapman H, Prostko JC, Frias EC, Stewart JL, Pozdnyakova V, Debbas P, Mujukian A, Horizon AA, Merin N, Joung S, Botwin GJ, Sobhani K, Figueiredo JC, Cheng S, Kaplan IM, McGovern DPB, Merchant A, Melmed GY, Braun J. PMID: 35397000; PMCID: PMC9047232.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    48. Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial. Am J Gastroenterol. 2022 09 01; 117(9):1508-1518. Almario CV, van Deen WK, Chen M, Gale R, Sidorkiewicz S, Choi SY, Bonthala N, Ha C, Syal G, Dupuy T, Liu X, Melmed GY, Spiegel BMR. PMID: 35973146; PMCID: PMC9450884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. Am J Gastroenterol. 2022 10 01; 117(10):1639-1647. Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 35973139.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 01; 21(1):173-181.e5. Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk JS, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai PS, Boland BS, Mahadevan U, Sandborn WJ, Ohno-Machado L, McGovern D, Singh S. PMID: 35644340; PMCID: PMC9701245.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis. BMJ Open. 2022 05 24; 12(5):e059994. Ebinger JE, Joung S, Liu Y, Wu M, Weber B, Claggett B, Botting PG, Sun N, Driver M, Kao YH, Khuu B, Wynter T, Nguyen TT, Alotaibi M, Prostko JC, Frias EC, Stewart JL, Goodridge HS, Chen P, Jordan SC, Jain M, Sharma S, Fert-Bober J, Van Eyk JE, Minissian MB, Arditi M, Melmed GY, Braun JG, McGovern DPB, Cheng S, Sobhani K. PMID: 35613792; PMCID: PMC9130668.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    52. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac171. Figueiredo JC, Hirsch FR, Kushi LH, Nembhard WN, Crawford JM, Mantis N, Finster L, Merin NM, Merchant A, Reckamp KL, Melmed GY, Braun J, McGovern D, Parekh S, Corley DA, Zohoori N, Amick BC, Du R, Gregersen PK, Diamond B, Taioli E, Sariol C, Espino A, Weiskopf D, Gifoni A, Brien J, Hanege W, Lipsitch M, Zidar DA, Scheck McAlearney A, Wajnberg A, LaBaer J, Yvonne Lewis E, Binder RA, Moormann AM, Forconi C, Forrester S, Batista J, Schieffelin J, Kim D, Biancon G, VanOudenhove J, Halene S, Fan R, Barouch DH, Alter G, Pinninti S, Boppana SB, Pati SK, Latting M, Karaba AH, Roback J, Sekaly R, Neish A, Brincks AM, Granger DA, Karger AB, Thyagarajan B, Thomas SN, Klein SL, Cox AL, Lucas T, Furr-Holden D, Key K, Jones N, Wrammerr J, Suthar M, Yu Wong S, Bowman NM, Simon V, Richardson LD, McBride R, Krammer F, Rana M, Kennedy J, Boehme K, Forrest C, Granger SW, Heaney CD, Knight Lapinski M, Wallet S, Baric RS, Schifanella L, Lopez M, Fernández S, Kenah E, Panchal AR, Britt WJ, Sanz I, Dhodapkar M, Ahmed R, Bartelt LA, Markmann AJ, Lin JT, Hagan RS, Wolfgang MC, Skarbinski J. PMID: 35765315; PMCID: PMC9129196.
      View in: PubMed   Mentions: 6  
    53. Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. Front Immunol. 2022; 13:880190. Xu AM, Li D, Ebinger JE, Mengesha E, Elyanow R, Gittelman RM, Chapman H, Joung S, Botwin GJ, Pozdnyakova V, Debbas P, Mujukian A, Prostko JC, Frias EC, Stewart JL, Horizon AA, Merin N, Sobhani K, Figueiredo JC, Cheng S, Kaplan IM, McGovern DPB, Merchant A, Melmed GY, Braun J. PMID: 35464463; PMCID: PMC9024211.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    54. Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection. Crohns Colitis 360. 2022 Apr; 4(2):otac011. Long MD, Zhang X, Lewis JD, Melmed GY, Siegel CA, Cerciello E, Dobes A, Weaver A, Weisbein L, Kappelman MD. PMID: 36777042; PMCID: PMC9037404.
      View in: PubMed   Mentions: 1  
    55. Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Mar 14; 16(3):379-388. Tse CS, Van Citters AD, Ricci B, Freundlich NZ, Lee M, Shah SA, Melmed GY, Siegel CA, van Deen WK, IBD Qorus . PMID: 34350943.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process. Inflamm Bowel Dis. 2022 03 02; 28(3):327-336. Oliver BJ, Kennedy AM, van Deen WK, Weaver SA, Heller C, Holthoff MM, Bank J, Melmed GY, Siegel CA, Nelson EC. PMID: 34037211.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Acute Severe Colitis: The Need for Joint Management between Gastroenterologists and Surgeons. Clin Colon Rectal Surg. 2022 Jan; 35(1):66-71. Fleshner P, Melmed GY. PMID: 35069032; PMCID: PMC8763454.
      View in: PubMed   Mentions: 1  
    58. Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology. Dig Dis Sci. 2022 10; 67(10):4687-4694. Syal G, Sparrow MP, Velayos F, Cheifetz AS, Devlin S, Irving PM, Kaplan GG, Raffals LE, Ullman T, Gecse KB, Fleshner PR, Lightner AL, Siegel CA, Melmed GY. PMID: 35006492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. J Transl Med. 2021 12 30; 19(1):524. Liu Y, Ebinger JE, Mostafa R, Budde P, Gajewski J, Walker B, Joung S, Wu M, Bräutigam M, Hesping F, Rupieper E, Schubert AS, Zucht HD, Braun J, Melmed GY, Sobhani K, Arditi M, Van Eyk JE, Cheng S, Fert-Bober J. PMID: 34965855; PMCID: PMC8716184.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsPHPublic Health
    60. The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders. medRxiv. 2021 12 08. Li D, Xu A, Mengesha E, Elyanow R, Gittelman RM, Chapman H, Prostko JC, Frias EC, Stewart JL, Pozdnyakova V, Debbas P, Mujukian A, Horizon AA, Merin N, Joung S, Botwin GJ, Sobhani K, Figueiredo JC, Cheng S, Kaplan IM, McGovern DPB, Merchant A, Melmed GY, Braun J. PMID: 34909785.
      View in: PubMed   Mentions:
    61. Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. medRxiv. 2021 Dec 07. Li D, Debbas P, Cheng S, Braun J, McGovern DPB, Melmed GY. PMID: 34909797; PMCID: PMC8669864.
      View in: PubMed   Mentions: 1  
    62. Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2459-2464. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY. PMID: 34730561.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2410-2418. Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA, IBD Qorus. PMID: 34797226.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    64. Point-of-care dashboards promote coproduction of healthcare services for patients with inflammatory bowel disease. Int J Qual Health Care. 2021 Nov 29; 33(Supplement_2):ii40-ii47. Van Citters AD, Holthoff MM, Kennedy AM, Melmed GY, Oberai R, Siegel CA, Weaver A, Nelson EC. PMID: 34849970.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    65. Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021 11 15; 27(12):2034-2037. Ghafari-Saravi A, Rabizadeh S, Dubovsky A, Miller S, Melmed GY, van Deen WK. PMID: 34037212.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Ultraviolet-A light increases mitochondrial anti-viral signaling protein in confluent human tracheal cells via cell-cell signaling. J Photochem Photobiol B. 2022 Jan; 226:112357. Leite G, Rezaie A, Mathur R, Barlow GM, Melmed GY, Pimentel M. PMID: 34798503; PMCID: PMC8590474.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    67. Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer. Cancer Res. 2021 12 15; 81(24):6273-6280. Figueiredo JC, Merin NM, Hamid O, Choi SY, Lemos T, Cozen W, Nguyen N, Finster LJ, Foley J, Darrah J, Gong J, Paquette R, Mita AC, Vescio R, Mehmi I, Basho R, Tourtellotte WG, Huynh CA, Melmed GY, Braun J, McGovern DPB, Mengesha E, Botwin G, Prostko JC, Frias EC, Stewart JL, Joung S, Van Eyk J, Ebinger JE, Cheng S, Sobhani K, Reckamp KL, Merchant A. PMID: 34759001; PMCID: PMC9060668.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsPHPublic Health
    68. Symptomology following mRNA vaccination against SARS-CoV-2. Prev Med. 2021 12; 153:106860. Ebinger JE, Lan R, Sun N, Wu M, Joung S, Botwin GJ, Botting P, Al-Amili D, Aronow H, Beekley J, Coleman B, Contreras S, Cozen W, Davis J, Debbas P, Diaz J, Driver M, Fert-Bober J, Gu Q, Heath M, Herrera E, Hoang A, Hussain SK, Huynh C, Kim L, Kittleson M, Liu Y, Lloyd J, Luong E, Malladi B, Merchant A, Merin N, Mujukian A, Nguyen N, Nguyen TT, Pozdnyakova V, Rashid M, Raedschelders K, Reckamp KL, Rhoades K, Sternbach S, Vallejo R, White S, Tompkins R, Wong M, Arditi M, Figueiredo JC, Van Eyk JE, Miles PB, Chavira C, Shane R, Sobhani K, Melmed GY, McGovern DPB, Braun JG, Cheng S, Minissian MB. PMID: 34687733; PMCID: PMC8527734.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    69. Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View. Inflamm Bowel Dis. 2021 10 20; 27(11):1747-1755. Dubinsky MC, Watanabe K, Molander P, Peyrin-Biroulet L, Rubin M, Melmed GY, Deuring JJ, Woolcott J, Cappelleri JC, Steinberg K, Connor S. PMID: 33529314; PMCID: PMC8528151.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    70. Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom. Inflamm Bowel Dis. 2021 10 18; 27(10):1593-1601. Patel DB, van Deen WK, Almario CV, Khalil C, Warui E, Bonthala N, Melmed GY, Spiegel BMR. PMID: 33300555.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease. Ann Intern Med. 2021 12; 174(12):1768-1770. Melmed GY, Botwin GJ, Sobhani K, Li D, Prostko J, Figueiredo J, Cheng S, Braun J, McGovern DPB. PMID: 34633830; PMCID: PMC8513793.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    72. Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease. Dis Colon Rectum. 2021 10 01; 64(10):1259-1266. Parrish AB, Lopez NE, Truong A, Zaghiyan K, Melmed GY, McGovern DPB, Ha C, Syal G, Bonthala N, Jain A, Landers CJ, Targan SR, Fleshner P. PMID: 34516445.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Extensive Upper Gastrointestinal Fistulization in Crohn's Disease, an Uncommon Cause for a Common Presentation. Am J Gastroenterol. 2021 10 01; 116(10):1978. Ashhab AA, Lee M, Melmed GY. PMID: 34618695.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. Am J Gastroenterol. 2021 10 01; 116(10):2014-2025. Cheifetz AS, Abreu MT, Afif W, Cross RK, Dubinsky MC, Loftus EV, Osterman MT, Saroufim A, Siegel CA, Yarur AJ, Melmed GY, Papamichael K. PMID: 34388143; PMCID: PMC9674375.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    75. Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2022 09; 20(9):1947-1970.e7. Fudman DI, Perez-Reyes AE, Niccum BA, Melmed GY, Khalili H. PMID: 34481951.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Endoscopic evaluation after surgery in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2021 09; 6(9):690-691. Syal G, Fleshner PR, Melmed GY. PMID: 34391521.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology. 2021 12; 161(6):2041-2043.e1. Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z. PMID: 34391771; PMCID: PMC8359492.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    78. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Gastroenterology. 2021 08; 161(2):681-700. Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. PMID: 34334167.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    79. Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 08 01; 116(8):1746-1751. Botwin GJ, Li D, Figueiredo J, Cheng S, Braun J, McGovern DPB, Melmed GY. PMID: 34047304; PMCID: PMC8484025.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    80. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. J Can Assoc Gastroenterol. 2021 Aug; 4(4):e59-e71. Benchimol EI, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Jones JL. PMID: 34476338; PMCID: PMC8407487.
      View in: PubMed   Mentions: 5  
    81. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. J Can Assoc Gastroenterol. 2021 Aug; 4(4):e72-e91. Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. PMID: 34476339; PMCID: PMC8407486.
      View in: PubMed   Mentions: 10  
    82. Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience. Inflamm Bowel Dis. 2021 07 27; 27(8):1248-1255. Halloran BP, Jamil LH, Lo SK, Reeson M, Vasiliauskas EA, Targan S, Ippoliti A, Mann NK, Melmed GY. PMID: 33155643.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    83. Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus. Photodiagnosis Photodyn Ther. 2021 Sep; 35:102457. Leite G, Pimentel M, Mathur R, Barlow GM, Chan Y, Melmed GY, Rezaie A. PMID: 34314863; PMCID: PMC8310417.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    84. Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosis. Colorectal Dis. 2021 Sep; 23(9):2416-2424. Truong A, Zaghiyan KN, Mirocha J, Melmed GY, McGovern DPB, Syal G, Ha CY, Targan SR, Fleshner PR. PMID: 34157179; PMCID: PMC8440372.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study. Adv Ther. 2021 08; 38(8):4556-4568. Rezaie A, Melmed GY, Leite G, Mathur R, Takakura W, Pedraza I, Lewis M, Murthy R, Chaux G, Pimentel M. PMID: 34173969; PMCID: PMC8234768.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    86. Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure. J Crohns Colitis. 2021 Jun 22; 15(6):960-968. Syal G, Shemtov R, Bonthala N, Vasiliauskas EA, Feldman EJ, Zaghiyan K, Ha CY, McGovern DPB, Targan SR, Melmed GY, Fleshner PR. PMID: 33300546; PMCID: PMC8218713.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    87. The Reliability of Patient Self-reported Utilization in an Inflammatory Bowel Diseases Learning Health System. Crohns Colitis 360. 2021 Jul; 3(3):otab031. van Deen WK, Freundlich N, Kwon MH, Patel DB, Crate DJ, Oberai R, Shah SA, Hwang C, Weaver SA, Siegel CA, Melmed GY. PMID: 36776667; PMCID: PMC9802108.
      View in: PubMed   Mentions: 4  
    88. Reply. Gastroenterology. 2021 07; 161(1):369-370. Melmed G, Rubin DT, McGovern D. PMID: 33831380; PMCID: PMC8162783.
      View in: PubMed   Mentions:    Fields:    
    89. Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease. medRxiv. 2021 Mar 31. Botwin GJ, Li D, Figueiredo J, Cheng S, Braun J, McGovern DPB, Melmed GY. PMID: 33821287; PMCID: PMC8020989.
      View in: PubMed   Mentions:
    90. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Gastroenterology. 2021 08; 161(2):669-680.e0. Benchimol EI, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Jones JL. PMID: 33617891.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    91. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. 2021 Apr; 70(4):635-640. Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). PMID: 33472895; PMCID: PMC7818789.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCellsPHPublic Health
    92. Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection? Am J Gastroenterol. 2020 11; 115(11):1797-1798. Banty A, Melmed GY. PMID: 33156097.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    93. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic. Gastroenterology. 2021 02; 160(3):639-644. Melmed GY, Rubin DT, McGovern DPB. PMID: 33065064; PMCID: PMC7553998.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    94. Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay. J Clin Med. 2020 Sep 02; 9(9). Papamichael K, Thomas VJ, Banty A, Clarke WT, Germansky KA, Flier SN, Feuerstein JD, Melmed GY, Cheifetz AS. PMID: 32887317; PMCID: PMC7565738.
      View in: PubMed   Mentions: 1  
    95. Ultraviolet A light effectively reduces bacteria and viruses including coronavirus. PLoS One. 2020; 15(7):e0236199. Rezaie A, Leite GGS, Melmed GY, Mathur R, Villanueva-Millan MJ, Parodi G, Sin J, Germano JF, Morales W, Weitsman S, Kim SY, Park JH, Sakhaie S, Pimentel M. PMID: 32673355; PMCID: PMC7365468.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    96. Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care Pathway. Clin Gastroenterol Hepatol. 2020 11; 18(12):2645-2649.e4. Hwang C, Issokson K, Giguere-Rich C, Reddy S, Tinsley A, Van Deen WK, Bray H, Lum D, Aguilar H, Zisman TL, Younes Z, Crate D, Oberai R, Weaver A, Melmed G, Siegel C, Hou JK. PMID: 32599016.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    97. cBIN1 Score (CS) Identifies Ambulatory HFrEF Patients and Predicts Cardiovascular Events. Front Physiol. 2020; 11:503. Hitzeman TC, Xie Y, Zadikany RH, Nikolova AP, Baum R, Caldaruse AM, Agvanian S, Melmed GY, McGovern DPB, Geft DR, Chang DH, Moriguchi JD, Hage A, Azarbal B, Czer LS, Kittleson MM, Patel JK, Wu AHB, Kobashigawa JA, Hamilton M, Hong T, Shaw RM. PMID: 32670075; PMCID: PMC7326053.
      View in: PubMed   Mentions: 6  
    98. A qualitative inquiry into patients' perspectives on individualized priorities for treatment outcomes in inflammatory bowel diseases. Qual Life Res. 2020 Sep; 29(9):2403-2414. van Deen WK, Kiaei B, Weaver SA, Crate DJ, Kwon MH, Shah SA, Melmed GY, Siegel CA. PMID: 32279196.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2021 01; 66(1):199-205. Syal G, Robbins L, Kashani A, Bonthala N, Feldman E, Fleshner P, Vasiliauskas E, McGovern D, Ha C, Targan S, Melmed GY. PMID: 32170473.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    100. Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 04; 19(4):839-841.e2. Papamichael K, Clarke WT, Vande Casteele N, Germansky KA, Feuerstein JD, Melmed GY, Siegel CA, Irving PM, Cheifetz AS. PMID: 32147594; PMCID: PMC7483237.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    101. Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases? Inflamm Bowel Dis. 2020 03 04; 26(4):603-605. Syal G, Melmed GY. PMID: 31504529.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    102. Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization. Dig Dis Sci. 2020 06; 65(6):1777-1783. Berry SK, Takakura W, Bresee C, Melmed GY. PMID: 31654314.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    103. Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study. Inflamm Bowel Dis. 2019 10 18; 25(11):e143-e145. Clarke WT, Papamichael K, Vande Casteele N, Germansky KA, Feuerstein JD, Melmed GY, Siegel CA, Irving PM, Cheifetz AS. PMID: 31559417.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    104. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 05 16; 25(Suppl 2):S40-S47. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA. PMID: 31095704.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    105. The Role of Histology in Determining Disease Activity, Treatment, and Prognosis: Are We There yet? Gastrointest Endosc Clin N Am. 2019 Jul; 29(3):437-446. Salem MS, Melmed GY. PMID: 31078246.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    106. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 08; 17(9):1655-1668.e3. Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA. PMID: 30928454; PMCID: PMC6661210.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    107. Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives. Inflamm Bowel Dis. 2019 01 10; 25(2):403-409. Bitton A, Vutcovici M, Lytvyak E, Kachan N, Bressler B, Jones J, Lakatos PL, Sewitch M, El-Matary W, Melmed G, Nguyen G, QI consensus group, Promoting Access and Care through Centers of Excellence-PACE program). PMID: 30169582.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    108. Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology. Inflamm Bowel Dis. 2019 01 10; 25(2):328-335. Weizman AV, Nguyen GC, Seow CH, Targownik L, Murthy SK, Boland K, Afzal NM, Khanna R, Jones J, Afif W, Halder S, Reinglas J, Fowler S, Huang V, Kaplan GG, Melmed GY. PMID: 30346529.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    109. A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study. Inflamm Bowel Dis. 2018 11 29; 24(12):2550-2554. Lee CK, Melmed GY, Mann A, Danovitch I, Hedrick R, McGovern DPB, Targan S, Shih D, Vasiliauskas E, IsHak WW, Feldman E. PMID: 29920581.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. Reply. Clin Gastroenterol Hepatol. 2018 11; 16(11):1840. Melmed GY, Cohen ER. PMID: 30343867.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis. 2018 09 15; 24(10):2258-2265. Winthrop KL, Melmed GY, Vermeire S, Long MD, Chan G, Pedersen RD, Lawendy N, Thorpe AJ, Nduaka CI, Su C. PMID: 29850873; PMCID: PMC6140434.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCellsCTClinical Trials
    112. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study. Gastrointest Endosc. 2018 12; 88(6):947-955.e2. Melmed GY, Dubinsky MC, Rubin DT, Fleisher M, Pasha SF, Sakuraba A, Tiongco F, Shafran I, Fernandez-Urien I, Rosa B, Papageorgiou NP, Leighton JA. PMID: 30086261.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    113. Improving Quality in the Care of Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2018 07 12; 24(8):1660-1669. Egberg MD, Gulati AS, Gellad ZF, Melmed GY, Kappelman MD. PMID: 29718299; PMCID: PMC6231366.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    114. Moving on After Discontinuation of Anti-TNF Therapy-What Comes Next? J Crohns Colitis. 2018 05 25; 12(6):633-634. Abbasi SQ, Melmed GY. PMID: 29701765.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Making a Case for Patient-Reported Outcomes in Clinical Inflammatory Bowel Disease Practice. Clin Gastroenterol Hepatol. 2018 05; 16(5):603-607. Cohen ER, Melmed GY. PMID: 29678238.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    116. Therapy for Crohn's Disease: a Review of Recent Developments. Curr Gastroenterol Rep. 2018 Apr 05; 20(5):19. Eustace GJ, Melmed GY. PMID: 29623492.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    117. Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All. Clin Gastroenterol Hepatol. 2018 11; 16(11):1829-1831. Melmed GY, Kaplan GG, Sparrow MP, Velayos FS, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Irving PM, Jones J, Kozuch PL, Raffals LE, Siegel CA. PMID: 29505910.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care? Gastroenterology. 2018 03; 154(4):1201-1202. Papamichael K, Osterman MT, Siegel CA, Melmed GY, Dubinsky MC, Colombel JF, Hanauer SB, Cheifetz AS. PMID: 29432749.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    119. Quality indicators in inflammatory bowel disease. Intest Res. 2018 Jan; 16(1):43-47. Berry SK, Melmed GY. PMID: 29422796; PMCID: PMC5797270.
      View in: PubMed   Mentions: 10  
    120. The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study. Inflamm Bowel Dis. 2018 01 18; 24(2):387-393. Rolston VS, Boroujerdi L, Long MD, McGovern DPB, Chen W, Martin CF, Sandler RS, Carmichael JD, Dubinsky M, Melmed GY. PMID: 29361085; PMCID: PMC6196767.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    121. Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease. J Dig Dis. 2018 Jan; 19(1):15-23. Gu P, Kapur A, Li D, Haritunians T, Vasiliauskas E, Shih DQ, Targan SR, Spiegel BM, Mcgovern DP, Black JT, Melmed GY. PMID: 29251413; PMCID: PMC6023617.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    122. Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis. Am J Gastroenterol. 2018 01; 113(1):58-71. Almario CV, Keller MS, Chen M, Lasch K, Ursos L, Shklovskaya J, Melmed GY, Spiegel BMR. PMID: 29206816.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    123. Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD. Inflamm Bowel Dis. 2017 08; 23(8):1382-1393. Yoon SM, Haritunians T, Chhina S, Liu Z, Yang S, Landers C, Li D, Ye BD, Shih D, Vasiliauskas EA, Ippoliti A, Rabizadeh S, Targan SR, Melmed GY, McGovern DPB. PMID: 28590340; PMCID: PMC6510223.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    124. Quality Improvement Initiatives in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2017 Aug; 19(8):41. Berry SK, Siegel CA, Melmed GY. PMID: 28730508.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    125. Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 06; 23(6):858-865. Nguyen GC, Boland K, Afif W, Bressler B, Jones JL, Weizman AV, Fowler S, Halder S, Huang VW, Kaplan GG, Khanna R, Murthy SK, Ruel J, Seow CH, Targownik LE, Chawla T, Guimaraes L, Fernandes A, Saleh S, Melmed GY. PMID: 28509817.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    126. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Jul; 112(7):1208. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. PMID: 28534523.
      View in: PubMed   Mentions: 2     Fields:    
    127. Multidisciplinary Team-Based Approaches to IBD Management: How Might "One-Stop Shopping" Work for Complex IBD Care? Am J Gastroenterol. 2017 06; 112(6):825-827. Lee CK, Melmed GY. PMID: 28508869.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    128. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis. 2017 05; 23(5):798-803. IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J, Danovitch I, Melmed GY. PMID: 28301432.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    129. Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2017 04; 23(4):570-577. Shah ED, Farida JP, Siegel CA, Chong K, Melmed GY. PMID: 28230558.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    130. Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales. Dig Dis Sci. 2017 05; 62(5):1186-1192. Khanna D, Hays RD, Shreiner AB, Melmed GY, Chang L, Khanna PP, Bolus R, Whitman C, Paz SH, Hays T, Reise SP, Spiegel B. PMID: 28251500; PMCID: PMC5532518.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    131. Fostering Collaboration Through Creation of an IBD Learning Health System. Am J Gastroenterol. 2017 Mar; 112(3):406-408. Johnson LC, Melmed GY, Nelson EC, Holthoff MM, Weaver SA, Morgan TS, Siegel CA. PMID: 28195179.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    132. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 02; 112(2):241-258. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. PMID: 28071656.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    133. Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2017 01; 23(1):35-43. Hou JK, Gasche C, Drazin NZ, Weaver SA, Ehrlich OG, Oberai R, Zapala S, Siegel CA, Melmed G. PMID: 27749376.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    134. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil. 2017 05; 29(5). Lee AD, Spiegel BM, Hays RD, Melmed GY, Bolus R, Khanna D, Khanna PP, Chang L. PMID: 27981684; PMCID: PMC5393974.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    135. Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers. Inflamm Bowel Dis. 2016 10; 22(10):2474-81. Tinsley A, Ehrlich OG, Hwang C, Issokson K, Zapala S, Weaver A, Siegel CA, Melmed GY. PMID: 27598738.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    136. Effects of caregiver burden on quality of life and coping strategies utilized by caregivers of adult patients with inflammatory bowel disease. Ann Gastroenterol. 2017; 30(1):89-95. Parekh NK, Shah S, McMaster K, Speziale A, Yun L, Nguyen DL, Melmed G, Kane S. PMID: 28042243; PMCID: PMC5198253.
      View in: PubMed   Mentions: 18  
    137. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis. Dig Dis Sci. 2016 10; 61(10):2972-2976. Cleveland NK, Rodriquez D, Wichman A, Pan I, Melmed GY, Rubin DT. PMID: 27557706.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    138. Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol. Curr Med Res Opin. 2016 12; 32(12):1937-1941. Melmed GY, McGovern D, Schreiber S, Kosutic G, Spearman M, Coarse J, Sandborn WJ. PMID: 27494777.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    139. A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease. Am J Gastroenterol. 2016 Nov; 111(11):1599-1607. Targan SR, Feagan B, Vermeire S, Panaccione R, Melmed GY, Landers C, Li D, Russell C, Newmark R, Zhang N, Chon Y, Hsu YH, Lin SL, Klekotka P. PMID: 27481309.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansCTClinical Trials
    140. Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis. J Crohns Colitis. 2017 Jan; 11(1):77-83. Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D, Rabizadeh S, Singh N, Landers C, Ippoliti A, Shih D, Targan S, Fleshner P. PMID: 27466172.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    141. Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis. Inflamm Bowel Dis. 2016 06; 22(6):1397-402. Koh SZ, Zaghiyan KN, Li Q, Rabizadeh S, Melmed GY, Targan SR, Fleshner PR. PMID: 26978722.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    142. Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis. 2016 06; 22(6):1418-24. Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA. PMID: 27057680.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    143. Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results. Clin Gastroenterol Hepatol. 2016 09; 14(9):1302-9. Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA. PMID: 27189916.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    144. Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials. Inflamm Bowel Dis. 2016 Apr; 22(4):933-9. Shah ED, Siegel CA, Chong K, Melmed GY. PMID: 26818417.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    145. Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway. Inflamm Bowel Dis. 2016 Apr; 22(4):862-9. Kaur M, Panikkath D, Yan X, Liu Z, Berel D, Li D, Vasiliauskas EA, Ippoliti A, Dubinsky M, Shih DQ, Melmed GY, Haritunians T, Fleshner P, Targan SR, McGovern DP. PMID: 26937622; PMCID: PMC5220246.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    146. How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Apr; 12(4):240-4. Katz S, Melmed G. PMID: 27231455; PMCID: PMC4872854.
      View in: PubMed   Mentions: 8  
    147. Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulcerative Colitis. Inflamm Bowel Dis. 2016 Mar; 22(3):654-61. Ahmed S, Melmed G, McGovern D, Robbins LA, Shih D, Vasiliauskas E, Singh N, Rabidzadeh S, Ippoliti A, Targan S, Fleshner P. PMID: 26595552.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    148. Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium. Pancreas. 2015 Nov; 44(8):1195-210. Afghani E, Pandol SJ, Shimosegawa T, Sutton R, Wu BU, Vege SS, Gorelick F, Hirota M, Windsor J, Lo SK, Freeman ML, Lerch MM, Tsuji Y, Melmed GY, Wassef W, Mayerle J. PMID: 26465949; PMCID: PMC4890478.
      View in: PubMed   Mentions: 38     Fields:    
    149. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits. J Crohns Colitis. 2016 Jan; 10(1):43-9. Taleban S, Li D, Targan SR, Ippoliti A, Brant SR, Cho JH, Duerr RH, Rioux JD, Silverberg MS, Vasiliauskas EA, Rotter JI, Haritunians T, Shih DQ, Dubinsky M, Melmed GY, McGovern DP. PMID: 26449790; PMCID: PMC6082592.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    150. Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis. Dig Dis Sci. 2016 Feb; 61(2):550-9. Taleban S, Van Oijen MG, Vasiliauskas EA, Fleshner PR, Shen B, Ippoliti AF, Targan SR, Melmed GY. PMID: 26434930.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    151. Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015 Aug; 21(8):1754-60. Dezfoli S, Horton HA, Thepyasuwan N, Berel D, Targan SR, Vasiliauskas EA, Dubinsky M, Shih DQ, Kaur M, McGovern DP, Ippoliti A, Feldman EJ, Melmed GY. PMID: 25985242.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    152. Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study. Inflamm Bowel Dis. 2015 Aug; 21(8):1809-16. Melmed GY, Pandak WM, Casey K, Abraham B, Valentine J, Schwartz D, Awais D, Bassan I, Lichtiger S, Sands B, Hanauer S, Richards R, Oikonomou I, Parekh N, Targan S, Johnson K, Hariri R, Fischkoff S. PMID: 25985246.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    153. Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2233-40.e1-2; quiz e177-8. Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA. PMID: 26142167.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    154. Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study. Aliment Pharmacol Ther. 2015 Aug; 42(3):330-42. Sandborn WJ, Melmed GY, McGovern DP, Loftus EV, Choi JM, Cho JH, Abraham B, Gutierrez A, Lichtenstein G, Lee SD, Randall CW, Schwartz DA, Regueiro M, Siegel CA, Spearman M, Kosutic G, Pierre-Louis B, Coarse J, Schreiber S. PMID: 26031921.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    155. Coping Strategies Used by Adult Patients with Inflammatory Bowel Disease. South Med J. 2015 Jun; 108(6):337-42. Parekh NK, McMaster K, Nguyen DL, Shah S, Speziale A, Miller J, Melmed G. PMID: 26079458.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    156. Implementing quality measures for inflammatory bowel disease. Curr Gastroenterol Rep. 2015 Apr; 17(4):14. Ahmed S, Siegel CA, Melmed GY. PMID: 25762473.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    157. Corrigendum: development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2015 Apr; 110(4):608. Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, Khanna PP, Paz SH, Hays T, Reise S, Khanna D. PMID: 25853211.
      View in: PubMed   Mentions:    Fields:    
    158. Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability. Dig Dis Sci. 2015 Aug; 60(8):2408-18. Shah ED, Siegel CA, Chong K, Melmed GY. PMID: 25772778.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    159. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. J Cutan Med Surg. 2015 Mar-Apr; 19(2):125-31. Weizman AV, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, Ippoliti A, Panikkath D, Vasiliauskas E, Shih D, McGovern DP, Melmed GY. PMID: 25775631.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    160. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg. 2015 Mar; 261(3):487-96. Lau C, Dubinsky M, Melmed G, Vasiliauskas E, Berel D, McGovern D, Ippoliti A, Shih D, Targan S, Fleshner P. PMID: 24950263; PMCID: PMC4994811.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    161. Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis. Arthritis Care Res (Hoboken). 2014 Nov; 66(11):1725-30. Nagaraja V, Hays RD, Khanna PP, Spiegel BM, Chang L, Melmed GY, Bolus R, Khanna D. PMID: 24692332; PMCID: PMC4182150.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    162. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. Gastroenterology. 2015 Feb; 148(2):344-54.e5; quiz e14-5. Hazlewood GS, Rezaie A, Borman M, Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA, Melmed GY, Kaplan GG. PMID: 25448924.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    163. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. J Cutan Med Surg. 2014 Oct; 18(5):361. Weizman AV, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, Ippoliti A, Panikkath D, Vasiliauskas E, Shih D, McGovern DP, Melmed GY. PMID: 25277124; PMCID: PMC5089702.
      View in: PubMed   Mentions: 12     Fields:    
    164. Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2014 Oct; 20(10):1708-13. Singh N, Rosenthal CJ, Melmed GY, Mirocha J, Farrior S, Callejas S, Tripuraneni B, Rabizadeh S, Dubinsky MC. PMID: 25153505.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    165. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2014 Nov; 109(11):1804-14. Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, Khanna PP, Paz SH, Hays T, Reise S, Khanna D. PMID: 25199473; PMCID: PMC4285435.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    166. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Qual Life Res. 2015 Jan; 24(1):163-79. Spiegel BM, Reid MW, Bolus R, Whitman CB, Talley J, Dea S, Shahedi K, Karsan H, Teal C, Melmed GY, Cohen E, Fuller G, Yen L, Hodgkins P, Erder MH. PMID: 25059533.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    167. Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease. Antimicrob Agents Chemother. 2014 Sep; 58(9):5054-9. Horton HA, Dezfoli S, Berel D, Hirsch J, Ippoliti A, McGovern D, Kaur M, Shih D, Dubinsky M, Targan SR, Fleshner P, Vasiliauskas EA, Grein J, Murthy R, Melmed GY. PMID: 24913174; PMCID: PMC4135854.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    168. GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci. 2014 Oct; 59(10):2488-96. Cohen E, Bolus R, Khanna D, Hays RD, Chang L, Melmed GY, Khanna P, Spiegel B. PMID: 24811245; PMCID: PMC4275099.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    169. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Mar; 20(3):525-33. Weizman A, Huang B, Berel D, Targan SR, Dubinsky M, Fleshner P, Ippoliti A, Kaur M, Panikkath D, Brant S, Oikonomou I, Duerr R, Rioux J, Silverberg M, Rotter JI, Vasiliauskas E, Haritunians T, Shih D, Li D, Melmed GY, McGovern DP. PMID: 24487271; PMCID: PMC4046633.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    170. Significant variation in recommendation of care for women of reproductive age with ulcerative colitis postileal pouch-anal anastomosis. Dig Dis Sci. 2014 Jun; 59(6):1115-20. Bradford K, Melmed GY, Fleshner P, Silverman N, Dubinsky MC. PMID: 24549832.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    171. Vaccinations in older adults with gastrointestinal diseases. Clin Geriatr Med. 2014 Feb; 30(1):17-28. Horton HA, Kim H, Melmed GY. PMID: 24267599.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    172. A prospective, randomized, noninferiority trial of steroid dosing after major colorectal surgery. Ann Surg. 2014 Jan; 259(1):32-7. Zaghiyan K, Melmed GY, Berel D, Ovsepyan G, Murrell Z, Fleshner P. PMID: 23774314.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    173. Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. Am J Gastroenterol. 2014 Feb; 109(2):234-48. Khanna P, Agarwal N, Khanna D, Hays RD, Chang L, Bolus R, Melmed G, Whitman CB, Kaplan RM, Ogawa R, Snyder B, Spiegel BM. PMID: 24343547; PMCID: PMC4275098.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    174. Weeding out the facts: the reality about cannabis and Crohn's disease. Clin Gastroenterol Hepatol. 2014 May; 12(5):898-9. Vu MP, Melmed GY, Targan SR. PMID: 24269921.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    175. Video capsule endoscopy impacts decision making in pediatric IBD: a single tertiary care center experience. Inflamm Bowel Dis. 2013 Sep; 19(10):2139-45. Min SB, Le-Carlson M, Singh N, Nylund CM, Gebbia J, Haas K, Lo S, Mann N, Melmed GY, Rabizadeh S, Dubinsky MC. PMID: 23867872.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    176. Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Aug; 11(8):908-12. Siegel CA, Allen JI, Melmed GY. PMID: 23747710.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    177. Quality improvement in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013 May; 9(5):286-92. Melmed GY, Siegel CA. PMID: 23943663; PMCID: PMC3740804.
      View in: PubMed   Mentions: 25  
    178. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):754-60. Mayer L, Pandak WM, Melmed GY, Hanauer SB, Johnson K, Payne D, Faleck H, Hariri RJ, Fischkoff SA. PMID: 23429460; PMCID: PMC4272923.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    179. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8. Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA. PMID: 23388547.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    180. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm Bowel Dis. 2013 Jan; 19(1):30-6. Le Q, Melmed G, Dubinsky M, McGovern D, Vasiliauskas EA, Murrell Z, Ippoliti A, Shih D, Kaur M, Targan S, Fleshner P. PMID: 22467562; PMCID: PMC4457327.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    181. Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale. Dig Dis Sci. 2013 May; 58(5):1313-21. Surti B, Spiegel B, Ippoliti A, Vasiliauskas EA, Simpson P, Shih DQ, Targan SR, McGovern DP, Melmed GY. PMID: 23250673; PMCID: PMC4161217.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    182. Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y). 2012 Aug; 8(8):504-12. Dezfoli S, Melmed GY. PMID: 23293563; PMCID: PMC3533208.
      View in: PubMed   Mentions: 10  
    183. High-dose perioperative corticosteroids in steroid-treated patients undergoing major colorectal surgery: necessary or overkill? Am J Surg. 2012 Oct; 204(4):481-6. Zaghiyan KN, Murrell Z, Melmed GY, Fleshner PR. PMID: 22748293.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    184. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease? Dis Colon Rectum. 2012 May; 55(5):563-8. White EC, Melmed GY, Vasiliauskas E, Dubinsky M, Ippoliti A, McGovern D, Targan S, Fleshner P. PMID: 22513435.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    185. Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study. Surgery. 2012 Aug; 152(2):158-63. Zaghiyan K, Melmed G, Murrell Z, Fleshner P. PMID: 22503320.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    186. Facial ulceration in a patient with Crohn's disease. Gastroenterology. 2012 May; 142(5):1071, 1258. Huang B, Melmed GY, Shih DQ. PMID: 22440954.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    187. Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups. Inflamm Bowel Dis. 2012 Dec; 18(12):2294-300. Cheifetz AS, Melmed GY, Spiegel B, Talley J, Devlin SM, Raffals L, Irving PM, Jones J, Kaplan GG, Kozuch P, Sparrow M, Velayos F, Baidoo L, Bressler B, Siegel CA. PMID: 22337359.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    188. Colorectal cancer screening and surveillance in Crohn's colitis. J Crohns Colitis. 2012 Sep; 6(8):824-9. Basseri RJ, Basseri B, Vassilaki ME, Melmed GY, Ippoliti A, Vasiliauskas EA, Fleshner PR, Lechago J, Hu B, Berel D, Targan SR, Papadakis KA. PMID: 22398087.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    189. Comparison of adenoma detection rates between gastroenterologists and colorectal surgeons. Am Surg. 2012 Feb; 78(2):269-70. Ollington KF, Brelian D, Morgan J, Le Q, Fleshner P, Melmed GY. PMID: 22369845.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    190. Vaccinations while on thiopurines: some protection is better than none. Am J Gastroenterol. 2012 Jan; 107(1):141-2. Melmed GY. PMID: 22218037.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    191. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine. 2012 Feb 14; 30(8):1413-24. Agarwal N, Ollington K, Kaneshiro M, Frenck R, Melmed GY. PMID: 22197580.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    192. Are high-dose perioperative steroids necessary in patients undergoing colorectal surgery treated with steroid therapy within the past 12 months? Am Surg. 2011 Oct; 77(10):1295-9. Zaghiyan K, Melmed G, Murrell Z, Fleshner P. PMID: 22127073.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    193. Immunizations and IBD: whose responsibility is it? If I'm the prescribing doctor, shouldn't it be mine? Inflamm Bowel Dis. 2012 Jan; 18(1):41-2. Melmed GY. PMID: 21351213.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    194. Phantom publications among applicants to a colorectal surgery residency program. Dis Colon Rectum. 2011 Feb; 54(2):220-5. Nasseri Y, Kohanzadeh S, Murrell Z, Berel D, Melmed G, Fleshner P. PMID: 21228672.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    195. Variants in ZNF365 isoform D are associated with Crohn's disease. Gut. 2011 Aug; 60(8):1060-7. Haritunians T, Jones MR, McGovern DP, Shih DQ, Barrett RJ, Derkowski C, Dubinsky MC, Dutridge D, Fleshner PR, Ippoliti A, King L, Leshinsky-Silver E, Levine A, Melmed GY, Mengesha E, Vasilauskas EA, Ziaee S, Rotter JI, Targan SR, Taylor KD. PMID: 21257989; PMCID: PMC3250380.
      View in: PubMed   Mentions: 13     Fields:    
    196. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis. 2010 Nov; 16(11):1830-40. Haritunians T, Taylor KD, Targan SR, Dubinsky M, Ippoliti A, Kwon S, Guo X, Melmed GY, Berel D, Mengesha E, Psaty BM, Glazer NL, Vasiliauskas EA, Rotter JI, Fleshner PR, McGovern DP. PMID: 20848476; PMCID: PMC2959149.
      View in: PubMed   Mentions: 57     Fields:    
    197. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease. Inflamm Bowel Dis. 2010 Aug; 16(8):1279-85. Ippoliti A, Devlin S, Mei L, Yang H, Papadakis KA, Vasiliauskas EA, McGovern DP, Abreu MT, Melmed G, Shaye O, Enayati P, Chen G, Choi J, Taylor K, Landers CJ, Rotter JI, Targan SR. PMID: 20027650; PMCID: PMC3875376.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    198. A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. Dis Colon Rectum. 2010 Jul; 53(7):987-94. White E, Melmed GY, Vasiliauskas EA, Dubinsky M, Berel D, Targan SR, Fleshner PR. PMID: 20551749; PMCID: PMC5002988.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    199. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet. 2010 Sep 01; 19(17):3468-76. McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, Ippoliti A, Vasiliauskas E, Berel D, Derkowski C, Dutridge D, Fleshner P, Shih DQ, Melmed G, Mengesha E, King L, Pressman S, Haritunians T, Guo X, Targan SR, Rotter JI, International IBD Genetics Consortium. PMID: 20570966; PMCID: PMC2916706.
      View in: PubMed   Mentions: 174     Fields:    Translation:Humans
    200. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):655-9. Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Siegel CA. PMID: 20451665.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    201. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010 Apr; 42(4):332-7. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D'Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard EJ, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK, NIDDK IBD Genetics Consortium, Sharma Y, Silverberg MS, Cho JH, Wu J, Roeder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seielstad M. PMID: 20228799; PMCID: PMC3087600.
      View in: PubMed   Mentions: 281     Fields:    
    202. Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis. Dis Colon Rectum. 2010 Mar; 53(3):293-300. Murrell Z, Vasiliauskas E, Melmed G, Lo S, Targan S, Fleshner P. PMID: 20173476.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    203. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol. 2010 Feb; 7(2):110-7. Melmed GY, Targan SR. PMID: 20134493.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    204. Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis. 2010 Jan; 16(1):134-6. Siegel CA, Melmed GY, Ullman TA. PMID: 19637384.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    205. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010 Jan; 105(1):148-54. Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, Simpson P, Barolet-Garcia C, Ward J, Targan SR, Vasiliauskas EA. PMID: 19755964.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    206. Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis. Am J Gastroenterol. 2010 Jan; 105(1):155-61. Nasseri Y, Melmed G, Wang HL, Targan S, Fleshner P. PMID: 19755970.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    207. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009 Sep; 15(9):1410-6. Melmed GY. PMID: 19462435.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    208. A new method for endoscopic closure of gastrocolonic fistula: novel application of a cardiac septal defect closure device (with video). Gastrointest Endosc. 2009 Sep; 70(3):542-5. Melmed GY, Kar S, Geft I, Lo SK. PMID: 19699982.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    209. Predicting response to Anti-TNF Agents for the treatment of crohn's disease. Therap Adv Gastroenterol. 2009 Jul; 2(4):245-51. Siegel CA, Melmed GY. PMID: 21180547; PMCID: PMC3002521.
      View in: PubMed   Mentions: 35  
    210. A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. Dis Colon Rectum. 2009 May; 52(5):872-8. Murrell ZA, Melmed GY, Ippoliti A, Vasiliauskas EA, Dubinsky M, Targan SR, Fleshner PR. PMID: 19502850.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    211. Clarithromycin for Crohn's: A flash in the pan? Inflamm Bowel Dis. 2009 Apr; 15(4):639-40. Melmed GY. PMID: 18942746.
      View in: PubMed   Mentions: 1     Fields:    
    212. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci. 2010 Feb; 55(2):398-403. Hwang L, Low K, Khoshini R, Melmed G, Sahakian A, Makhani M, Pokkunuri V, Pimentel M. PMID: 19294509.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    213. New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy. Dig Dis Sci. 2010 Jan; 55(1):145-9. Pimentel M, Hwang L, Melmed GY, Low K, Vasiliauskas E, Ippoliti A, Yang J, Lezcano S, Conklin JL, Sahakian A. PMID: 19169820.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    214. Vaccinations and the Utilization of Immunosuppressive IBD Therapy. Gastroenterol Hepatol (N Y). 2008 Dec; 4(12):859-61. Melmed GY. PMID: 21904475; PMCID: PMC3093688.
      View in: PubMed   Mentions: 3  
    215. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1759-68. Spiegel BM, Melmed G, Robbins S, Esrailian E. PMID: 18832106; PMCID: PMC2572281.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    216. Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y). 2008 Oct; 4(10):713-20. Sparrow MP, Irving PM, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Jones J, Kozuch PL, Melmed GY, Velayos FS, Siegel CA. PMID: 21960891; PMCID: PMC3104182.
      View in: PubMed   Mentions:
    217. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):168-74, 174.e1. Spiegel BM, Ho W, Esrailian E, Targan S, Higgins PD, Siegel CA, Dubinsky M, Melmed GY. PMID: 18952199; PMCID: PMC3804428.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    218. Certolizumab pegol. Nat Rev Drug Discov. 2008 Aug; 7(8):641-2. Melmed GY, Targan SR, Yasothan U, Hanicq D, Kirkpatrick P. PMID: 18670430.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    219. Proximal small intestinal CD detected by CE. Gastrointest Endosc. 2008 Jul; 68(1):202-3; author reply 203-4. Melmed GY, Fleshner PR, Papadakis KA. PMID: 18577488.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    220. The impact of medical therapy for inflammatory bowel disease on pregnancy outcome. Am J Gastroenterol. 2008 Mar; 103(3):805-6. Simpson PW, Melmed GY, Dubinksy M. PMID: 18341506.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    221. Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis. Clin Gastroenterol Hepatol. 2008 Mar; 6(3):360-3. Melmed GY, Devlin SM, Vlotides G, Dhall D, Ross S, Yu R, Melmed S. PMID: 18255351; PMCID: PMC2696478.
      View in: PubMed   Mentions: 4     Fields:    
    222. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008 Jan; 51(1):100-8. Melmed GY, Fleshner PR, Bardakcioglu O, Ippoliti A, Vasiliauskas EA, Papadakis KA, Dubinsky M, Landers C, Rotter JI, Targan SR. PMID: 18085333; PMCID: PMC2442922.
      View in: PubMed   Mentions: 34     Fields:    
    223. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. Clin Gastroenterol Hepatol. 2007 May; 5(5):602-8; quiz 525. Melmed GY, Elashoff R, Chen GC, Nastaskin I, Papadakis KA, Vasiliauskas EA, Liu W, Landers C, Ippoliti AF, Targan SR. PMID: 17478347.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    224. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther. 2007 Feb 15; 25(4):487-500. Dubois RW, Aguilar D, Fass R, Orr WC, Elfant AB, Dean BB, Harper AS, Yu HT, Melmed GY, Lynn R, Singh A, Tedeschi M. PMID: 17270005.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    225. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology. 2007 Feb; 132(2):576-86. Devlin SM, Yang H, Ippoliti A, Taylor KD, Landers CJ, Su X, Abreu MT, Papadakis KA, Vasiliauskas EA, Melmed GY, Fleshner PR, Mei L, Rotter JI, Targan SR. PMID: 17258734.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    226. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006 Aug; 101(8):1834-40. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA. PMID: 16817843.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansPHPublic Health
    227. Capsule endoscopy: practical applications. Clin Gastroenterol Hepatol. 2005 May; 3(5):411-22. Melmed GY, Lo SK. PMID: 15880309.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    228. New insights into the pathogenesis of inflammatory bowel disease. Curr Gastroenterol Rep. 2004 Dec; 6(6):474-81. Melmed GY, Abreu MT. PMID: 15527677.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    229. Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the Literature. J Clin Rheumatol. 2004 Aug; 10(4):178-89. Dubois RW, Melmed GY, Henning JM, Bernal M. PMID: 17043507.
      View in: PubMed   Mentions: 9     Fields:    
    230. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther. 2004 Jan 15; 19(2):197-208. Dubois RW, Melmed GY, Henning JM, Laine L. PMID: 14723611.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    231. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol. 2003 Feb 01; 170(3):1406-15. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT. PMID: 12538701.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    232. Quality of life at the end of life: trends in patients with metastatic prostate cancer. Urology. 2002 Jan; 59(1):103-9. Melmed GY, Kwan L, Reid K, Litwin MS. PMID: 11796290.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    233. Life after radical prostatectomy: a longitudinal study. J Urol. 2001 Aug; 166(2):587-92. Litwin MS, Melmed GY, Nakazon T. PMID: 11458073.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    Gil's Networks
    Concepts (566)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (61)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California